GWPH Insider Trading Activity and SEC Form 4 Filings
GWPH insider trading summary
No open-market insider purchases or sales of Gw Pharmaceuticals PLC (GWPH) have been reported on SEC Form 4 in the past 12 months.
Latest GWPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 26, 2021 | Douglas B. Snyder | Chief Legal Officer | Sell | $152K (8,400 @ $18.12) |
| Mar 26, 2021 | Volker Knappertz | Director | Sell | $55K (3,060 @ $18.10) |
| Mar 18, 2021 | Cabot Brown | Director | Sell | $72K (4,020 @ $17.95) |
| Jan 22, 2021 | Adam D. George | Secretary | Sell | $172K (14,700 @ $11.69) |
| Jan 21, 2021 | Adam D. George | Secretary | Sell | $14K (1,200 @ $11.76) |
| Jan 21, 2021 | Adam D. George | Secretary | Sell | $273K (23,388 @ $11.69) |
| Jan 19, 2021 | Volker Knappertz | Chief Medical Officer | Sell | $70K (6,000 @ $11.67) |
| Jan 19, 2021 | Adam D. George | Secretary | Sell | $112K (9,600 @ $11.68) |
| Jan 15, 2021 | Adam D. George | Secretary | Sell | $626K (53,376 @ $11.72) |
| Jan 15, 2021 | Adam D. George | Secretary | Sell | $311K (26,484 @ $11.75) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.